CN Patent

CN113797167B — 一种塞纳布啡的储库制剂

Assigned to Suzhou Enhua Biomedical Technology Co ltd · Expires 2024-05-10 · 2y expired

What this patent protects

本发明为一种塞纳布啡的储库制剂，属于医疗领域，具体涉及一种纳布啡癸二酸酯的低粘度储库前体组合物，包含酰基甘油、磷脂酰胆碱、至少一种含氧有机溶剂、至少一种非离子型稳定性两亲物质和纳布啡癸二酸酯，所得到的低粘度储库前体组合物具有更高的载药量和更少的注射体积，可减少注射部位疼痛和刺激。

USPTO Abstract

本发明为一种塞纳布啡的储库制剂，属于医疗领域，具体涉及一种纳布啡癸二酸酯的低粘度储库前体组合物，包含酰基甘油、磷脂酰胆碱、至少一种含氧有机溶剂、至少一种非离子型稳定性两亲物质和纳布啡癸二酸酯，所得到的低粘度储库前体组合物具有更高的载药量和更少的注射体积，可减少注射部位疼痛和刺激。

Drugs covered by this patent

Patent Metadata

Patent number
CN113797167B
Jurisdiction
CN
Classification
—
Expires
2024-05-10
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Enhua Biomedical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.